Ocular diseases present a unique challenge and opportunity for therapeutic development.
The eye has distinct advantages as a therapy target given its accessibility …

Age-related ocular diseases, such as age-related macular degeneration (AMD), diabetic
retinopathy, and glaucoma, result in life-long functional deficits and enormous global health …

Chronic ocular diseases can seriously impact the eyes and could potentially result in
blindness or serious vision loss. According to the most recent data from the WHO, there are …

Ocular diseases include various anterior and posterior segment diseases. Due to the unique
anatomy and physiology of the eye, efficient ocular drug delivery is a great challenge to …

Adequate and persistent drug delivery to the target tissues is a key bottleneck in drug
development for eye diseases. Additionally, early diagnosis of eye diseases and …

An external file that holds a picture, illustration, etc. Object name is bi-6-49-g009. jpg
Introduction: Ocular targeted therapy has enormously been advanced by implementation of …

Various cellular and tissue targets in ocular drug treatment have distinct challenges of drug
delivery. Anterior targets are involved in the treatment of infections, inflammatory conditions …

Recent advances in molecular cell biology have led to the exploration of new therapies
based on molecules, cells, and genes to treat a variety of ocular disorders. In this review, we …

Ocular diseases, such as age-related macular degeneration (AMD) and glaucoma, have
had a profound impact on millions of patients. In the past couple of decades, these diseases …

Ocular diseases profoundly impact patients' vision and overall quality of life globally.
However, effective ocular drug delivery presents formidable challenges within clinical …